Biortica Agrimed

What Biortica Agrimed does

Biortica Agrimed is a privately held, for-profit Australian company founded in 2019 and headquartered in Richmond, Australia. The firm operates in the medicinal cannabis sector under a B2B model, serving licensed producers, formulators, and pharmaceutical counterparties rather than end consumers. According to the firmographic description, its offering spans four pillars: proprietary cannabis genetics, cultivation services, GMP-compliant manufacturing, and a cannabis-as-a-service product line.

The company's reported capabilities cluster around regulated, capital-intensive activities — specifically GMP manufacturing and proprietary genetic IP — both of which require license authorization and cultivar development respectively. Headcount sits in the 11-50 band, consistent with a small-scale, vertically integrated operator rather than a commodity producer. No product SKU detail, pricing model, contract structure, or customer segmentation is documented in the available input; the company's own website returned a loader/verification page without substantive disclosure.

Direct verification of operational status, revenue, funding, partnerships, management, certifications, and product specifics is not possible from the supplied material. The single most informative data point remains the firmographic self-description. Without additional disclosure, the company's defensibility hinges on the regulatory and biological-asset layers — GMP certification and proprietary genetics — rather than software, distribution, or platform breadth. Investors evaluating the company should treat the brief as a starting hypothesis rather than a confirmed operational profile.

Name

Biortica Agrimed

Website

https://biortica.com

Company type

Private

Founded year

2019

Headcount range

11–50 employees

Short description

Biortica Agrimed is an Australian B2B medicinal cannabis company offering proprietary cannabis genetics, contract cultivation, GMP-compliant manufacturing, and cannabis-as-a-service to licensed producers and pharmaceutical counterparties. Founded 2019, based in Richmond, Australia.

Ownership category

akta.pro rank

Headquarters

HQ city

Richmond

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Core offering

Biortica Agrimed provides B2B medicinal cannabis solutions covering cannabis genetics, cultivation, GMP-compliant manufacturing, and cannabis-as-a-service offerings for business customers in the regulated medicinal cannabis industry. The company supplies licensed operators and other B2B buyers with the upstream inputs and contract manufacturing capacity needed to bring compliant medicinal cannabis products to market.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights3 records

Direct peers

• Little Green Pharma: Australian GMP-licensed medicinal cannabis cultivator and manufacturer with both domestic and export operations. Highly comparable to Biortica's B2B medicinal cannabis cultivation and GMP manufacturing model.
• Cann Group: Australian licensed medicinal cannabis producer with cultivation, manufacturing, and genetics capabilities. Operates in the same B2B medicinal cannabis vertical with similar regulatory exposure to TGA/ODC frameworks.
• Zelira Therapeutics: Australian-listed medicinal cannabis company focused on clinically validated cannabinoid formulations. Comparable as a regulated, Australian-based medicinal cannabis operator with manufacturing exposure.
• Althea Group Holdings: Australian medicinal cannabis company with cultivation, manufacturing, and product portfolio. Comparable in operating jurisdiction and B2B/wholesale exposure to Biortica.
• BOD Australia: Australian medicinal cannabis and CBD company with cultivation and product development capabilities. Overlaps with Biortica on the B2B medicinal cannabis supply chain.
• Creso Pharma: Australian-headquartered cannabis company with cultivation, GMP manufacturing, and international distribution. Direct peer in B2B medicinal cannabis supply and product development.

Emerging players

• Botanix Pharmaceuticals: Australian pharmaceutical company developing cannabinoid-based dermatology and antimicrobial products. Comparable in Australian cannabis-pharma operations, though focused on branded pharma rather than bulk B2B supply.
• Medlab Clinical: Australian pharmaceutical company with medicinal cannabis and nutraceutical products. Tangentially comparable as an Australian cannabis-pharma peer with cultivation and product exposure.

Broad incumbents

• Canopy Growth Corporation: Major global cannabis producer with established GMP operations and international distribution. Provides a reference point for the scale required to compete as a B2B medicinal cannabis platform.
• Tilray Brands: Large global cannabis operator with GMP-certified cultivation and manufacturing across multiple jurisdictions. Comparable as a B2B medicinal cannabis supplier at much greater scale, illustrating the competitive ceiling Biortica faces.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biortica Agrimed